
Hodogaya Chemical stock barely flickered coming into this Q1 2027 print, even though the trailing P/E of about 10x already priced it below many Japanese chemical peers. The headline this quarter is earnings power rather than revenue size. Basic earnings per share landed at ¥63.69 with net income of ¥1,014m on revenue of ¥12,808m. That leaves investors weighing a company that has recently improved its net margin to around 7% against a share price that has moved only modestly over the past month and sits slightly weaker over the last three months.
Is Hodogaya Chemical a straightforward value opportunity on a 10x P/E, or is the cheaper multiple masking real earnings and cash flow pressure? Compare the stock’s current pricing against earnings power in the valuation analysis for Hodogaya Chemical.Prefer clean charts over pages of Hodogaya Chemical figures and footnotes? See the full visual picture of Hodogaya Chemical, including how its valuation compares with its recent earnings power, in the interactive company report for Hodogaya Chemical.
For investors leaning positive on Hodogaya Chemical, the latest quarter gives some support. Revenue of ¥12,808m and net income of ¥1,014m, both higher than a year earlier, point to healthier earnings power in a traditionally steady chemicals mix. Basic EPS of ¥63.69 and a trailing net margin near 7% suggest the portfolio of functional colorants, specialty polymers and services is currently converting sales into profit more effectively than in the recent past.
The bear side is not fully erased. The share price is roughly flat over 7 and 30 days and still weaker over 90 days, which hints at investor hesitation despite better profitability. A trailing margin near 7% is an improvement on the prior 4.6% level but remains mid tier for specialty chemicals. With no fresh growth catalysts in view, Hodogaya Chemical still carries the perception risk of a cyclical industrial that needs to prove this earnings step up is sustainable.
After an earnings step up and a dividend that is not well covered by free cash flow, review our independent risk analysis for Hodogaya Chemical which shows 2 important warning signsIf Hodogaya Chemical's recent earnings step up and current 10x P/E have caught your attention, register for free with Simply Wall St and add it to a Watchlist to track share price against fair value and watch how sentiment responds over time. After you take a position, keep your focus with the Portfolio Command Center that cuts through noise and highlights the updates that matter for your holdings. For the longer term, compare your thinking on Hodogaya Chemical with thousands of other investors through the Community and see different angles on the same set of facts. By spotting potential catalysts and risks early, you give yourself a better chance to stay ahead of the market and make more confident decisions.
Fresh ideas can move before the headlines catch up. Spot quiet breakout momentum and stocks still under the radar for now, then move while it matters and get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com